Pamela Susan Douglas, MD

Professor of Medicine
Ursula Geller Distinguished Professor for Research in Cardiovascular Disease, in the School of Medicine
Member in the Duke Clinical Research Institute
Campus mail 200 Morris St Room 7710, Durham, NC 27701
Phone (919) 681-2690
Email address pamela.douglas@duke.edu

Pamela S Douglas MD is the Ursula Geller Professor of Research in Cardiovascular Diseases in the Department of Medicine at Duke University and Director of the Multimodality Imaging Program at Duke Clinical Research Institute. During her 30+ years of experience she has led several landmark multicenter government studies and pivotal industry clinical trials along with outcomes research studies.  She is renowned for her scientific and policy work in improving the quality and appropriateness of imaging in clinical care, clinical trials and registries and through development and dissemination of national standards for imaging utilization, informatics and analysis. She has been among the pioneers in a number of areas including heart disease in women, sports cardiology, and cardio-oncology. Dr. Douglas’ wealth of experience includes authorship of over 400 peer reviewed manuscripts and 30 practice guidelines, and service as the President of the American College of Cardiology, President of the American Society of Echocardiography, and Chief of Cardiology at both the University of Wisconsin and Duke University. She has also previously served on the faculties of the University of Pennsylvania and Harvard University. She currently serves on the External Advisory Council of the National Heart, Lung and Blood Institute and the Scientific Advisory Board of the Patient Advocate Foundation.

Education and Training

  • Fellow in Cardiology, Medicine, University of Pennsylvania, 1981 - 1984
  • Medical Resident, Medicine, University of Pennsylvania, 1978 - 1981
  • M.D., Virginia Commonwealth University, 1978

Publications

Fichtenbaum, Carl J., Heather J. Ribaudo, Jorge Leon-Cruz, Edgar T. Overton, Markella V. Zanni, Carlos D. Malvestutto, Judith A. Aberg, et al. “Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.” J Infect Dis 222, no. Supplement_1 (July 9, 2020): S8–19. https://doi.org/10.1093/infdis/jiaa259.

PMID
32645162
Full Text

Umbleja, Triin, Todd T. Brown, Edgar T. Overton, Heather J. Ribaudo, Jennifer A. Schrack, Kathleen V. Fitch, Pamela S. Douglas, et al. “Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARE.” J Infect Dis 222, no. Supplement_1 (July 9, 2020): S52–62. https://doi.org/10.1093/infdis/jiaa249.

PMID
32645163
Full Text

Overton, Edgar T., Amy Kantor, Kathleen V. Fitch, Paul Muntner, Khuanchai Supparatpinyo, Mosepele Mosepele, Lerato Mohapi, et al. “An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus.” J Infect Dis 222, no. Supplement_1 (July 9, 2020): S41–51. https://doi.org/10.1093/infdis/jiaa222.

PMID
32645164
Full Text

Neilan, Tomas G., Kim-Lien Nguyen, Vlad G. Zaha, Kara W. Chew, Leavitt Morrison, Ntobeko A. B. Ntusi, Mabel Toribio, et al. “Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial.” J Infect Dis 222, no. Supplement_1 (July 9, 2020): S63–69. https://doi.org/10.1093/infdis/jiaa245.

PMID
32645158
Full Text

Zanni, Markella V., Judith S. Currier, Amy Kantor, Laura Smeaton, Corinne Rivard, Jana Taron, Tricia H. Burdo, et al. “Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial.” J Infect Dis 222, no. Supplement_1 (July 9, 2020): S20–30. https://doi.org/10.1093/infdis/jiaa214.

PMID
32645159
Full Text

Smeaton, Laura M., Emma M. Kileel, Beatriz Grinsztejn, Edward M. Gardner, Kate Starr, Melissa L. Murry, Patrice Desvigne-Nickens, et al. “Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.” J Infect Dis 222, no. Supplement_1 (July 9, 2020): S31–40. https://doi.org/10.1093/infdis/jiaa213.

PMID
32645160
Full Text

Grinspoon, Steven K., Pamela S. Douglas, Udo Hoffmann, and Heather J. Ribaudo. “Leveraging a Landmark Trial of Primary Cardiovascular Disease Prevention in Human Immunodeficiency Virus: Introduction From the REPRIEVE Coprincipal Investigators.” J Infect Dis 222, no. Supplement_1 (July 9, 2020): S1–7. https://doi.org/10.1093/infdis/jiaa098.

PMID
32645161
Full Text

Roifman, Idan, Atul Sivaswamy, Anna Chu, Peter C. Austin, Dennis T. Ko, Pamela S. Douglas, and Harindra C. Wijeysundera. “Clinical Effectiveness of Cardiac Noninvasive Diagnostic Testing in Outpatients Evaluated for Stable Coronary Artery Disease.” J Am Heart Assoc 9, no. 13 (July 7, 2020): e015724. https://doi.org/10.1161/JAHA.119.015724.

PMID
32605412
Full Text

Bittner, Daniel O., Thomas Mayrhofer, Matt Budoff, Balint Szilveszter, Borek Foldyna, Travis R. Hallett, Alexander Ivanov, et al. “Prognostic Value of Coronary CTA in Stable Chest Pain: CAD-RADS, CAC, and Cardiovascular Events in PROMISE.” Jacc Cardiovasc Imaging 13, no. 7 (July 2020): 1534–45. https://doi.org/10.1016/j.jcmg.2019.09.012.

PMID
31734213
Full Text

Salaun, Erwan, Marie-Annick Clavel, Rebecca T. Hahn, Wael A. Jaber, Federico M. Asch, Leonardo Rodriguez, Neil J. Weissman, et al. “Outcome of Flow-Gradient Patterns of Aortic Stenosis After Aortic Valve Replacement: An Analysis of the PARTNER 2 Trial and Registry.” Circ Cardiovasc Interv 13, no. 7 (July 2020): e008792. https://doi.org/10.1161/CIRCINTERVENTIONS.119.008792.

PMID
32674676
Full Text

Pages